Jupiter Neurosciences, Inc. Common Stock (JUNS) support and resistance · rev $21.8K
Jupiter Neurosciences, Inc. Common Stock (JUNS) is a biotechnology company listed on NASDAQ.
This page maps Jupiter Neurosciences, Inc. Common Stock (JUNS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported JUNS revenue for 2025-12-31 was $21.8K. Net income was -$8.6M. JUNS currently screens at market cap $10.0M.
JUNS currently screens at market cap $10.0M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new JUNS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the JUNS quote page for the session range and the stock page for the full model.
Not investment advice.